PreMarket Price
ImmunityBio, Inc. Common Stock (IBRX) logo

ImmunityBio, Inc. Common Stock (IBRX)

Price: $9.14 · -1.61%

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

AnalystsStrong Buy10 analysts
Mkt Cap 9.69BROE -193.3%

What's happening with IBRX

Price History

5-Year Weekly Candlestick Chart

Insider Transactions

Recent SEC Form 4 filings

  • Sell
    Option exercise · filed 2026-07-06
    -55979 sh
    2026-07-02
  • Sell
    Open market sale · filed 2026-07-06
    -131210 sh
    2026-07-02
  • Buy
    Option exercise · filed 2026-07-06
    +56.0K sh
    2026-07-02
  • Sell
    Option exercise · filed 2026-07-06
    -124414 sh
    2026-07-01
  • Sell
    Option exercise · filed 2026-07-06
    -35064 sh
    2026-07-01

+3 more recent filings

See how IBRX ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Market Moves

See all IBRX moves →
DateSessionPriceMoveZ-Score
Sep 22Regular9.36+10.77%2.76
Sep 22After-hours9.32+10.30%2.64

Frequently Asked Questions about IBRX

What is the current ImmunityBio, Inc. Common Stock (IBRX) stock price?

IBRX is trading at $9.14 in pre-market trading, down 1.61% on the session. PreMarketPrice tracks IBRX pre-market, intraday and after-hours prices.

When does ImmunityBio, Inc. Common Stock report earnings?

No confirmed earnings date is currently scheduled for IBRX. The Earnings section lists recent reports and updates as dates are announced.

What sector does ImmunityBio, Inc. Common Stock operate in?

ImmunityBio, Inc. Common Stock operates in the Healthcare sector, within the Biological Products, (No Diagnostic Substances) industry. The Related Stocks section lists sector peers for comparison.

About ImmunityBio, Inc. Common Stock (IBRX) Stock

ImmunityBio, Inc. Common Stock (IBRX) is a US-listed stock operating in the Healthcare sector, specifically the Biological Products, (No Diagnostic Substances) industry. As of the latest update, ImmunityBio, Inc. Common Stock is trading at $9.14, down 1.61% on the day with a market capitalization of $9.7 billion. The financial health score for IBRX has not yet been calculated — analysis data is being compiled. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for IBRX stock.

IBRX Stock Analysis & Key Metrics

On PreMarketPrice, you can track ImmunityBio, Inc. Common Stock (IBRX) across multiple dimensions:

  • Pre-market price & movement: Real-time IBRX stock price with percentage change, updated continuously during pre-market and regular trading hours.
  • Financial health score: A composite score based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for IBRX.
  • Sector peers: Compare IBRX against 10 other healthcare stocks on key financial metrics.

Is IBRX a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate ImmunityBio, Inc. Common Stock (IBRX) as an investment. The financial health score is being calculated.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.ImmunityBio, Inc. Common Stock (IBRX) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.